CSIMarket
 


Forty Seven Inc   (FTSV)
Other Ticker:  
 
 

FTSV's Net Cash Flow Growth by Quarter and Year

Forty Seven Inc 's Net Cash Flow results by quarter and year




FTSV Net Cash Flow (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December 202.98 0.00 0.00 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   202.98 0.00 0.00 0.00



FTSV Net Cash Flow fourth quarter 2019 Y/Y Growth Comment
Forty Seven Inc in the fourth quarter 2019 achieved Net Cash Flow of $ 202.98 millions compare to net cash outflow recorded in same quarter a year ago.

According to the results reported in the fourth quarter 2019, Forty Seven Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Forty Seven Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2019.




FTSV Net Cash Flow ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Forty Seven Inc 's fourth quarter 2019 Net Cash Flow $ 202.98 millions FTSV's Income Statement
Forty Seven Inc 's fourth quarter 2018 Net Cash Flow $ 0.00 millions Quarterly FTSV's Income Statement
New: More FTSV's historic Net Cash Flow Growth >>


FTSV Net Cash Flow (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Forty Seven Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FTSV's IV. Quarter Q/Q Net Cash Flow Comment


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FTSV's IV. Quarter Q/Q Net Cash Flow Comment


Forty Seven Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
Cumulative Net Cash Flow 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
In the Dec 31 2019 period, Forty Seven Inc 's cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.

Forty Seven Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
In the Dec 31 2019 period, Forty Seven Inc 's cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.

Forty Seven Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
FTSV's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for FTSV's Competitors
Net Cash Flow Growth for Forty Seven Inc 's Suppliers
Net Cash Flow Growth for FTSV's Customers

You may also want to know
FTSV's Annual Growth Rates FTSV's Profitability Ratios FTSV's Asset Turnover Ratio FTSV's Dividend Growth
FTSV's Roe FTSV's Valuation Ratios FTSV's Financial Strength Ratios FTSV's Dividend Payout Ratio
FTSV's Roa FTSV's Inventory Turnover Ratio FTSV's Growth Rates FTSV's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2019
Xtl Biopharmaceuticals Ltd -1.03%$ -1.034 millions
Benitec Biopharma Inc -7.42%$ -7.424 millions
Ovid Therapeutics Inc -9.52%$ -9.519 millions
National Research Corporation-9.78%$ -9.776 millions
Dbv Technologies S a -10.96%$ -10.959 millions
Koninklijke Philips Nv-12.94%$ -12.945 millions
Taiwan Liposome Company Ltd -13.17%$ -13.171 millions
Itamar Medical Ltd -15.33%$ -15.334 millions
Cutera Inc -17.89%$ -17.893 millions
Lifevantage Corp-21.22%$ -21.222 millions
Fonar Corporation-23.86%$ -23.857 millions
Sanofi-24.81%$ -24.809 millions
Trillium Therapeutics Inc -29.49%$ -29.490 millions
Supernus Pharmaceuticals inc -29.86%$ -29.857 millions
Biolinerx Ltd -33.39%$ -33.386 millions
Xoma Corporation-37.12%$ -37.119 millions
Aeterna Zentaris Inc -37.93%$ -37.931 millions
Otonomy Inc -39.26%$ -39.259 millions
Morphosys Ag-40.64%$ -40.645 millions
Collegium Pharmaceutical Inc -41.88%$ -41.877 millions
Biohaven Ltd -44.33%$ -44.331 millions
Nabriva Therapeutics Plc-46.95%$ -46.948 millions
Neovasc Inc -47.21%$ -47.206 millions
Johnson and Johnson-48.51%$ -48.513 millions
Genetic Technologies Limited-50.06%$ -50.065 millions
Liquidia Corporation-54.34%$ -54.337 millions
Viveve Medical Inc -55.21%$ -55.209 millions
Motus Gi Holdings Inc -56.90%$ -56.902 millions
Cryoport inc -57.80%$ -57.799 millions
Kazia Therapeutics Limited-58.80%$ -58.796 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com